Showing results (2231-2240 of 2,316) with videos related to

Sort By:
Pageof 232
Eclinicalmedicine|July 3, 2023
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trialElena Zamagni, Stefania Oliva, Francesca Gay, et al.
Nature Communications|March 8, 2018
Convergent genomic signatures of domestication in sheep and goatsFlorian J Alberto, Frédéric Boyer, Pablo Orozco-terWengel, et al.
Physical Review Letters|July 21, 2023
Proof-of-Principle Experiment on the Dynamic Shell Formation for Inertial Confinement FusionI V Igumenshchev, W Theobald, C Stoeckl, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
Plos One|January 31, 2008
Differential screening of phage-ab libraries by oligonucleotide microarray technologyPaolo Monaci, Alessandra Luzzago, Claudia Santini, et al.
Physical Review Letters|May 27, 2022
Effect of Strongly Magnetized Electrons and Ions on Heat Flow and Symmetry of Inertial Fusion ImplosionsA Bose, J Peebles, C A Walsh, et al.
Global Change Biology|June 20, 2022
Microbiome assembly in thawing permafrost and its feedbacks to climateJessica G Ernakovich, Robyn A Barbato, Virginia I Rich, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 12, 2023
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of CardiologyJavier Escaned, Colin Berry, Bernard De Bruyne, et al.
Nature Medicine|January 15, 2026
Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trialCarlos Collet, Thabo Mahendiran, William F Fearon, et al.
Haematologica|December 20, 2024
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcomeSerena De Matteis, Laura Del Coco, Federica De Castro, et al.
Pageof 232